Risk Factors for Breast Cancer by Oestrogen Receptor Status: a Population-based Case-control Study

Overview

Journal Br J Cancer

Specialty Oncology

Date 1989 Jan 1

PMID 2757918

Citations 30

Authors

J A Cooper

T E Rohan

E L Cant

D J Horsfall

W D Tilley

Affiliations

Soon will be listed here.

Abstract

Data from a population-based case-control study conducted in Adelaide, South Australia, and involving 451 case-control pairs, were analysed to determine whether the associations of menstrual, reproductive, dietary and other factors with risk of breast cancer differed by oestrogen receptor (ER) status. Data on ER status were available for 380 cases. The proportion of tumours which were ER+ increased with age, and there was a higher proportion of ER+ tumours in post-menopausal than in premenopausal women. Both oral contraceptive use (P = 0.055) and cigarette smoking (P = 0.047) were associated with increased (unadjusted) risk of ER- cancer, while having little association with risk of ER+ cancer. Most dietary factors had little association with risk of either cancer type, the main exception being the reduction in risk of ER- breast cancer with increasing beta-carotene intake (P for trend = 0.017). In general, however, links with the factors examined were not strong enough to suggest different causal pathways for ER- and ER+ breast cancer.

Citing Articles

Reproductive Considerations for Patients with Early-Onset Breast Cancer.

Pleasant V, Ulrich N, Pearlman M, Moravek M Curr Breast Cancer Rep. 2024; 14(2):37-45.

PMID: 39525552 PMC: 11548833. DOI: 10.1007/s12609-022-00445-3.

SIRT1 mediates breast cancer development and tumorigenesis controlled by estrogen-related receptor β.

Parija M, Prakash S, Krishna B, Dash S, Mishra S Breast Cancer. 2024; 31(3):440-455.

PMID: 38421553 DOI: 10.1007/s12282-024-01555-9.

The effect of smoking on biological change of recurrent breast cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Kouhashi R, Yabumoto A J Transl Med. 2020; 18(1):153.

PMID: 32248830 PMC: 7132886. DOI: 10.1186/s12967-020-02307-x.

A prospective investigation of oral contraceptive use and breast cancer mortality: findings from the Swedish women's lifestyle and health cohort.

Nur U, El Reda D, Hashim D, Weiderpass E BMC Cancer. 2019; 19(1):807.

PMID: 31412822 PMC: 6694621. DOI: 10.1186/s12885-019-5985-6.

Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer.

Takada K, Kashiwagi S, Asano Y, Goto W, Takahashi K, Fujita H J Transl Med. 2019; 17(1):13.

PMID: 30616624 PMC: 6323676. DOI: 10.1186/s12967-019-1773-y.

References

DONEGAN W, Hartz A, Rimm A . The association of body weight with recurrent cancer of the breast. Cancer. 1978; 41(4):1590-4. DOI: 10.1002/1097-0142(197804)41:4<1590::aid-cncr2820410449>3.0.co;2-n. View

Wald N . Retinol, beta-carotene and cancer. Cancer Surv. 1987; 6(4):635-51. View

Hawkins R, Roberts M, Forrest A . Oestrogen receptors and breast cancer: current status. Br J Surg. 1980; 67(3):153-69. DOI: 10.1002/bjs.1800670302. View

Kelsey J . A review of the epidemiology of human breast cancer. Epidemiol Rev. 1979; 1:74-109. DOI: 10.1093/oxfordjournals.epirev.a036215. View

Moolgavkar S, Day N, Stevens R . Two-stage model for carcinogenesis: Epidemiology of breast cancer in females. J Natl Cancer Inst. 1980; 65(3):559-69. View

Ip C, Ip M . Serum estrogens and estrogen responsiveness in 7,12-dimethylbenz[a]anthracene-induced mammary tumors as influenced by dietary fat. J Natl Cancer Inst. 1981; 66(2):291-5. View

Elwood J, Godolphin W . Oestrogen receptors in breast tumours: associations with age, menopausal status and epidemiological and clinical features in 735 patients. Br J Cancer. 1980; 42(5):635-44. PMC: 2010532. DOI: 10.1038/bjc.1980.296. View

Lesser M, Rosen P, Senie R, Duthie K, Schwartz M . Estrogen and progesterone receptors in breast carcinoma: correlations with epidemiology and pathology. Cancer. 1981; 48(2):299-309. DOI: 10.1002/1097-0142(19810715)48:2<299::aid-cncr2820480215>3.0.co;2-2. View

Boyd N, Campbell J, Germanson T, Thomson D, Sutherland D, Meakin J . Body weight and prognosis in breast cancer. J Natl Cancer Inst. 1981; 67(4):785-9. View

10.

Mohla S, SAMPSON C, Khan T, Enterline J, Leffall Jr L, White J . Estrogen and progesterone receptors in breast cancer in Black Americans: Correlation of receptor data with tumor differentiation. Cancer. 1982; 50(3):552-9. DOI: 10.1002/1097-0142(19820801)50:3<552::aid-cncr2820500328>3.0.co;2-g. View

11.

Henderson B, Ross R, Pike M, Casagrande J . Endogenous hormones as a major factor in human cancer. Cancer Res. 1982; 42(8):3232-9. View

12.

McCarty Jr K, Silva J, Cox E, Leight Jr G, Wells Jr S, McCarty Sr K . Relationship of age and menopausal status to estrogen receptor content in primary carcinoma of the breast. Ann Surg. 1983; 197(2):123-7. PMC: 1353098. DOI: 10.1097/00000658-198302000-00001. View

13.

Osborne M, Rosen P, Lesser M, Schwartz M, Fishman J, Kinne D . The relationship between family history, exposure to exogenous hormones, and estrogen receptor protein in breast cancer. Cancer. 1983; 51(11):2134-8. DOI: 10.1002/1097-0142(19830601)51:11<2134::aid-cncr2820511130>3.0.co;2-f. View

14.

Hildreth N, Kelsey J, Eisenfeld A, Livolsi V, Holford T, Fischer D . Differences in breast cancer risk factors according to the estrogen receptor level of the tumor. J Natl Cancer Inst. 1983; 70(6):1027-31. View

15.

Baron J . Smoking and estrogen-related disease. Am J Epidemiol. 1984; 119(1):9-22. DOI: 10.1093/oxfordjournals.aje.a113730. View

16.

Baghurst K, Record S . A computerised dietary analysis system for use with diet diaries or food frequency questionnaires. Community Health Stud. 1984; 8(1):11-8. DOI: 10.1111/j.1753-6405.1984.tb00419.x. View

17.

Hulka B, Chambless L, WILKINSON W, Deubner D, McCarty Sr K, McCarty Jr K . Hormonal and personal effects on estrogen receptors in breast cancer. Am J Epidemiol. 1984; 119(5):692-704. DOI: 10.1093/oxfordjournals.aje.a113790. View

18.

Horsfall D, Tilley W, ORELL S, Marshall V, Cant E . Relationship between ploidy and steroid hormone receptors in primary invasive breast cancer. Br J Cancer. 1986; 53(1):23-8. PMC: 2001456. DOI: 10.1038/bjc.1986.4. View

19.

McTiernan A, Thomas D, Johnson L, Roseman D . Risk factors for estrogen receptor-rich and estrogen receptor-poor breast cancers. J Natl Cancer Inst. 1986; 77(4):849-54. View

20.

Stanford J, Szklo M, Brinton L . Estrogen receptors and breast cancer. Epidemiol Rev. 1986; 8:42-59. DOI: 10.1093/oxfordjournals.epirev.a036295. View